Telehealth Excellence Forum

Telehealth

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

Expert Insights Quiz

What does the future hold for the remote prescribing of controlled substances?

03/13/2023

Test your clinical knowledge with this quick quiz!

Test your clinical knowledge...

03/13/2023

Psych Congress Network

Videos

Part 2: Telepsychiatry’s Future: COVID-19’s Public Health Emergency End Explained

03/08/2023

Edward Kaftarian, MD, discusses how the end of the COVID-19 public health emergency will affect telepsychiatry practice, what clinicians can do to mitigate patient risk, and resources for learning more about telehealth regulations.

Edward Kaftarian, MD, discusses...

03/08/2023

Psych Congress Network

Videos

Telepsychiatry’s Future: COVID-19’s Public Health Emergency End Explained

03/02/2023

The COVID-19 public health emergency will end in May 2023--what does that mean for telepsychiatry?

The COVID-19 public health...

03/02/2023

Psych Congress Network

Drs Elisa Nelson, Christian Kohler, and Monica Calkins.

Q&As

Using Telehealth to Decrease Treatment Interference for First-Episode Psychosis Patients

02/22/2023

How successful is remote treatment for first-episode psychosis via telehealth? Learn more from Elisa Nelson, PhD, Monica Calkins, PhD, and Christian Kohler, PhD.

How successful is remote...

02/22/2023

Psych Congress Network

Q&As

Maintaining Continuity of Care for First-Episode Psychosis Through Telehealth

02/17/2023

For patients experiencing first-episode psychosis (FEP), specialty care in a dedicated setting is especially important to ensure consistent treatment engagement. How well does that specialty care translate to a telehealth setting?

For patients experiencing...

02/17/2023

Psych Congress Network

Expert Insights Quiz

Can psychotic disorders be treated via telehealth?

02/13/2023

Test your clinical knowledge with this quick quiz!

Test your clinical knowledge...

02/13/2023

Psych Congress Network

Videos

Using Telehealth to Deliver Behavioral Interventions for Children

02/07/2023

In Part 2 of this video Q&A, Dr Bagner details which new avenues he and his colleagues are exploring for the application of behavioral interventions delivered via telehealth.

In Part 2 of this video Q&A, Dr...

02/07/2023

Psych Congress Network

Videos

Delivering Parent-Child Interaction Therapy Via Telehealth

01/26/2023

In Part 1 of this video Q&A, Dr Bagner explains the study aims, methods, and results of practicing Parent-Child Interaction Therapy via telehealth

In Part 1 of this video Q&A, Dr...

01/26/2023

Psych Congress Network

Amber Hoberg, NP, and Edward Kaftarian, MD.

Podcasts

Taking a Mindful Approach to Telehealth Flexibility

01/18/2023

While telehealth offers flexibility to both provider and patient, clinicians should be cautious when treating patients in a virtual setting to ensure that the patient resides in the provider's state. In this podcast taken at Psych Congress...

While telehealth offers...

01/18/2023

Psych Congress Network

Wooden blocks with letters stack to spell "quiz"

Expert Insights Quiz

How can clinicians treat apprehensive patients via telehealth?

01/12/2023

Take this quick quiz to test your clinical knowledge!

Take this quick quiz to test...

01/12/2023

Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Rapid Refresh

Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics

04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...

Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...

Andrew Penn, MS, PMHNP, and...

04/11/2024

Psych Congress NP Institute

Rapid Refresh

Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder

04/10/2024

Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...

Amber Hoberg, PMHNP-BC,...

04/10/2024

Psych Congress NP Institute

Clinical Pearls

Tolerability Testing in Long-Acting Injectable Prescriptions

04/03/2024

Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.

Telehealth Excellence Forum

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

Sign Up

Specialties

Events

Year Round Education

HMP Global Products